Cargando…
Use of ribavirin in viruses other than hepatitis C. A review of the evidence()
Ribavirin is a molecule with antiviral activity against different viruses. In clinical practice, it has made its niche almost exclusively for the treatment of the hepatitis C virus. However, there are other diseases in which it could be of benefit and it has the advantage of being suitable for oral,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195261/ https://www.ncbi.nlm.nih.gov/pubmed/29907366 http://dx.doi.org/10.1016/j.eimce.2018.05.018 |
_version_ | 1783528496273817600 |
---|---|
author | Ramírez-Olivencia, German Estébanez, Miriam Membrillo, Francisco Javier Ybarra, Maria del Carmen |
author_facet | Ramírez-Olivencia, German Estébanez, Miriam Membrillo, Francisco Javier Ybarra, Maria del Carmen |
author_sort | Ramírez-Olivencia, German |
collection | PubMed |
description | Ribavirin is a molecule with antiviral activity against different viruses. In clinical practice, it has made its niche almost exclusively for the treatment of the hepatitis C virus. However, there are other diseases in which it could be of benefit and it has the advantage of being suitable for oral, intravenous and inhaled administration. We conducted a review of the indications of the main drug agencies (Spanish, European and American) and other possible indications, mainly haemorrhagic fevers and coronavirus. |
format | Online Article Text |
id | pubmed-7195261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71952612020-05-02 Use of ribavirin in viruses other than hepatitis C. A review of the evidence() Ramírez-Olivencia, German Estébanez, Miriam Membrillo, Francisco Javier Ybarra, Maria del Carmen Enferm Infecc Microbiol Clin (Engl Ed) Review Article Ribavirin is a molecule with antiviral activity against different viruses. In clinical practice, it has made its niche almost exclusively for the treatment of the hepatitis C virus. However, there are other diseases in which it could be of benefit and it has the advantage of being suitable for oral, intravenous and inhaled administration. We conducted a review of the indications of the main drug agencies (Spanish, European and American) and other possible indications, mainly haemorrhagic fevers and coronavirus. Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. 2019-11 2019-06-15 /pmc/articles/PMC7195261/ /pubmed/29907366 http://dx.doi.org/10.1016/j.eimce.2018.05.018 Text en © 2018 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Article Ramírez-Olivencia, German Estébanez, Miriam Membrillo, Francisco Javier Ybarra, Maria del Carmen Use of ribavirin in viruses other than hepatitis C. A review of the evidence() |
title | Use of ribavirin in viruses other than hepatitis C. A review of the evidence() |
title_full | Use of ribavirin in viruses other than hepatitis C. A review of the evidence() |
title_fullStr | Use of ribavirin in viruses other than hepatitis C. A review of the evidence() |
title_full_unstemmed | Use of ribavirin in viruses other than hepatitis C. A review of the evidence() |
title_short | Use of ribavirin in viruses other than hepatitis C. A review of the evidence() |
title_sort | use of ribavirin in viruses other than hepatitis c. a review of the evidence() |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195261/ https://www.ncbi.nlm.nih.gov/pubmed/29907366 http://dx.doi.org/10.1016/j.eimce.2018.05.018 |
work_keys_str_mv | AT ramirezolivenciagerman useofribavirininvirusesotherthanhepatitiscareviewoftheevidence AT estebanezmiriam useofribavirininvirusesotherthanhepatitiscareviewoftheevidence AT membrillofranciscojavier useofribavirininvirusesotherthanhepatitiscareviewoftheevidence AT ybarramariadelcarmen useofribavirininvirusesotherthanhepatitiscareviewoftheevidence |